Skip to content

Clinical trials

Schizophrenia trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Mexico Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20041
20051
20063
20071
20085
20091
20103
20114
20124
20133
20141
20152
20162
20172
20192
20213
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated5
Recruiting2
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Denovo Biopharma LLC4
Boehringer Ingelheim3
FORUM Pharmaceuticals Inc3
Hoffmann-La Roche3
Janssen Research & Development, LLC3
Alkermes, Inc.2
H. Lundbeck A/S2
Sumitomo Pharma America, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia45
Psychotic Disorders7
Bipolar Disorder3
Cognition Disorders3
Autistic Disorder1
Inflammation1
Mental Disorders1
Schizophrenia Spectrum and Other Psychotic Disorders1

Trials

Showing 26 to 45 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.